Allogeneic hematopoietic SCT for alpha-mannosidosis: An analysis of 17 patients

Bone Marrow Transplantation

Volumn 47, Issue 3, 2012, Pages 352-359

  Mynarek, M ^a   Tolar, J ^b   Albert, M H ^c   Escolar, M L ^d   Boelens, J J ^e   Cowan, M J ^f   Finnegan, N ^g   Glomstein, A ^h   Jacobsohn, D A ⁱ   Kuhl J S ^j   Yabe, H ^k   Kurtzberg, J ^l   Malm, D ^m   Orchard, P J ^b   Klein, C ^a   Lucke T ⁿ   Sykora, K W ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l DUKE UNIVERSITY MEDICAL CENTER   (United States)

^m UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

ⁿ RUHR UNIVERSITY BOCHUM   (Germany)

more..

Author keywords

alpha mannosidosis; hematopoietic SCT; inborn errors of metabolism; lysosomal storage disease; neurodevelopment; outcome

Indexed keywords

ALEMTUZUMAB; ALPHA MANNOSIDASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARNOLD CHIARI MALFORMATION; ARTICLE; AUDIOMETRY; CAUSE OF DEATH; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEARING AID; HIP DISLOCATION; HIP SURGERY; HUMAN; HUMAN CELL; HURLER SYNDROME; INFANT; INTERMETHOD COMPARISON; MALE; MANNOSIDOSIS; NERVE CELL DIFFERENTIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SKELETON MALFORMATION; SYNDROME DELINEATION; T CELL DEPLETION; THERAPY EFFECT; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ALPHA-MANNOSIDOSIS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MEDICAL ONCOLOGY; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84858069787     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.99     Document Type: Article

References (19)

1. Stinchi S, Lullmann-Rauch R, Hartmann D, Coenen R, Beccari T, Orlacchio A et al. Targeted disruption of the lysosomal alpha-mannosidase gene results in mice resembling a mild form of human alpha-mannosidosis. Hum Mol Genet 1999; 8: 1365-1372. (Pubitemid 29374069)
2. Michalski J, Haeuw J, Wieruszeski J, Montreuil J, Strecker G. In vitro hydrolysis of oligomannosyl oligosaccharides by the lysosomal alpha-d-mannosidases. Eur J Biochem 1990; 189: 369-379. (Pubitemid 20146021)
3. Malm D, Nilssen O. Alpha-mannosidosis. Orphanet J Rare Dis 2008; 3: 21.
4. Lyons MJ, Wood T, Espinoza L, Stensland HM, Holden KR. Early onset alpha-mannosidosis with slow progression in three Hispanic males. Dev Med Child Neurol 2007; 49: 854-857. (Pubitemid 350020448)
5. Yunis JJ, Lewandowski RC, Sanfilippo SJ, Tsai MY, Foni I, Bruhl HH. Clinical manifestations of mannosidosis - a longitudinal study. Am J Med 1976; 61: 841-848. (Pubitemid 8007444)
6. Berg T, Riise HMF, Hansen GM, Malm D, Tranebjærg L, Tollersrud OK et al. Spectrum of mutations in alpha-mannosidosis. Am J Hum Genet 1999; 64: 77-88.
7. Wong LT, Vallance H, Savage A, Davidson AG, Applegarth D. Oral zinc therapy in the treatment of alpha-mannosidosis. Am J Med Genet 1993; 46: 410-414. (Pubitemid 23149683)
8. Crawley AC, King B, Berg T, Meikle PJ, Hopwood JJ. Enzyme replacement therapy in alpha-mannosidosis guinea-pigs. Mol Genet Metab 2006; 89: 48-57. (Pubitemid 44205477)
9. Blanz J, Stroobants S, Lullmann-Rauch R, Morelle W, Ludemann M, D'Hooge R et al. Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice. Hum Mol Genet 2008; 17: 3437-3445.
10. Vite CH, McGowan JC, Niogi SN, Passini MA, Drobatz KJ, Haskins ME et al. Effective gene therapy for an inherited CNS disease in a large animal model. Ann Neurol 2005; 57: 355-364. (Pubitemid 40343957)
11. Walkley SU, Thrall MA, Dobrenis K, Huang M, March PA, Siegel DA et al. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc Natl Acad Sci USA 1994; 91: 2970-2974. (Pubitemid 24130156)
12. Albert MH, Schuster F, Peters C, Schulze S, Pontz BF, Muntau AC et al. T-cell-depleted peripheral blood stem cell transplantation for alpha-mannosidosis. Bone Marrow Transplant 2003; 32: 443-446. (Pubitemid 37038857)
13. Broomfield AA, Chakrapani A, Wraith JE. The effects of early and late bone marrow transplantation in siblings with alpha-mannosidosis. Is early haematopoietic cell transplantation the preferred treatment option? J Inherit Metab Dis 2010 Feb 18 (doi:10.1007/s10545-009-9035-4).
14. Grewal SS, Shapiro EG, Krivit W, Charnas L, Lockman LA, Delaney KA et al. Effective treatment of a-mannosidosis by allogeneic hematopoietic stem cell transplantation. J Pediatr 2004; 144: 569-573. (Pubitemid 38594755)
15. Wall DA, Grange DK, Goulding P, Daines M, Luisiri A, Kotagal S. Bone marrow transplantation for the treatment of alpha-mannosidosis. J Pediatr 1998; 133: 282-285. (Pubitemid 28385212)
16. Will A, Cooper A, Hatton C, Sardharwalla IB, Evans DI, Stevens RF. Bone marrow transplantation in the treatment of alpha-mannosidosis. Arch Dis Child 1987; 62: 1044-1049. (Pubitemid 17155053)
17. Aldenhofen M, Boelens J, DeKoenig TJ. The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 485-498. (Pubitemid 351494741)
18. Prasad VK, Kurtzberg J. Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions. Br J Haematol 2010; 148: 356-372.
19. Yabe H, Inoue H, Matsumoto M, Hamanoue S, Hiroi A, Koike T et al. Unmanipulated HLA-haploidentical bone marrow transplantation for the treatment of fatal, nonmalignant diseases in children and adolescents. Int J Hematol 2004; 80: 78-82. (Pubitemid 38937881)